Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

European Journal of Haematology

Volumn 76, Issue 2, 2006, Pages 134-140

  Iannitto, Emilio ^a   Minardi, Viviana ^a   Callea, Vincenzo ^b   Stelitano, Caterina ^b   Calvaruso, Giuseppina ^a   Tripodo, Claudio ^a   Quintini, Gerlando ^a   De Cantis, Stefano ^a   Ambrosetti, Achille ^c   Pizzolo, Giovanni ^c   Franco, Vito ^a   Florena, Ada M ^a   Abbadessa, Vincenzo ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Additional neoplasm; Lung cancer; Non Hodgkin's lymphoma; Second cancer; Splenic lymphoma with villous lymphocytes; Splenic marginal zone lymphoma

Indexed keywords

ALKYLATING AGENT; PURINE DERIVATIVE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIVER CARCINOMA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POPULATION; PRIORITY JOURNAL; SECOND CANCER; SPLENIC MARGINAL ZONE LYMPHOMA; URINARY TRACT TUMOR;

AGED; HUMANS; INCIDENCE; LYMPHOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SPLENIC NEOPLASMS;

EID: 33645051733     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00578.x     Document Type: Article

References (36)

1. V an L eeuwen FE T ravis LB Second cancers In D e V ita VT H ellman S R osenberg SA eds Cancer: Principles and Practice of Oncology 6th edn Philadelphia, PA Lippincott Williams & Wilkins 2001 2939 2964
2. H oppe RT Hodgkin's disease: complications of therapy and excess mortality Ann Oncol 1997 8 115 118
3. D ong C H emminki K Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms Br J Cancer 2001 85 997 1005
4. K osary CL R ies LAG M iller BA H ankey BF H arras A E dwards BK SEER Cancer Statistics Review 1973-1992: Tables and Graphs Bethesda, MD National Cancer Institute 1995 (NIH publication No. 96-2789)
5. N eugut AI M eadows AT R obinson E Introduction In N eugut AI M eadows AT R obinson E eds Multiple Primary Cancers Philadelphia, PA Lippincott Williams & Wilkins 1999 1 12
6. T ravis LB C urtis RE B oice JD H ankey BF F raumeni JF Second cancers following non-Hodgkin's lymphoma Cancer 1991 67 2002 2009
7. B rennan P C oates M A rmstrong B C olin D B offetta P Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia Br J Cancer 2000 82 1344 1347
8. H isada M B iggar RJ G reene MH F raumeni JF T ravis LB Solid tumors after chronic lymphocytic leukemia Blood 2001 98 1979 1981
9. F ederico M Z inzani PL F rassoldati A et al Risk of second cancers in patients with hairy cell leukemia: long-term follow-up J Clin Oncol 2002 20 638 646
10. B arista I C abanillas F R omaguera JE K houri IF Y ang Y S mith TL S trom SS M edeiros LJ H agemeister FB Is there an increased rate of additional malignancies in patients with mantle cell lymphoma? Ann Oncol 2002 13 318 322
11. A ndre M M ounier N L eleu X et al Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients Blood 2004 103 1222 1228
12. Z ucca E P inotti G R oggero E C omi MA P ascarella A C apella C P edrinis E C avalli F High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma Ann Oncol 1995 6 726 728
13. L uppi M L ongo G F errari MG F errara L M arasca R B arozzi P M orselli M E milia G T orelli G Prevalence of HCV infection and second neoplasms in marginal zone lymphomas Br J Haematol 1997 96 873 874
14. F ranco V F lorena AM I annitto E Splenic marginal zone lymphoma Blood 2003 101 2464 2472
15. I annitto E A mbrosetti A A mmatuna E et al Splenic marginal zone lymphoma with or without villous lymphocytes Cancer 2004 101 2050 2057
16. T hieblemont C F elman P B erger F D umontet C A rnaud P H equet O Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients Clin Lymphoma 2002 3 41 47
17. P arry -J ones N M atutes E G ruszka -W estwood AM S wansbury GJ W otherspoon AC C atovsky D Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients Br J Haematol 2003 120 759 764
18. I saacson PG P iris MA C atovsky D S werdlow S M ontserrat E B erger F M uller -H ermelink HK N athwani B H arris NL Splenic marginal zone lymphoma In J affe ES H arris NL S tein H V ardiman JW eds Tumors of Haematopoietic and Lymphoid Tissues. W.H.O. Classification of Tumors Lyon IARC Press 2001 135 137
19. H owe HL A review of the definition for multiple primary cancers in the United States In H owe HL ed Workshop Proceedings December 4-6, 2002. Princeton, NJ Springfield, IL North American Association of Central Cancer Registries 2003 1 40
20. The R Project for Statistical Computing (Accessed 7 June 2004)
21. K aplan EL M eier P Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53 457 481
22. K albfleisch JB P rentice RL The Statistical Analysis of Failure Time Data New York Wiley 1980
23. M ulligan S M atutes E D earden C C atovsky D Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases Br J Haematol 1991 78 206 209
24. T ravis LB C urtis RE G limelius B H olowaty E V an L eeuwen FE L ynch CF A dami J G ospodarowicz M W acholder S I nskip P et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma J Natl Cancer Inst 1993 85 1932 1937
25. N ishikubo CY K unkel LA F iglin R B elldegrun A R osen P E lashoff R W ang H T errito MC An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients Cancer 1996 78 2421 2426
26. A nderson CM P usztai L P almer JL C abanillas F E llerhorst JA Coincident renal cell carcinoma and non-Hodgkin's lymphoma: the M.D. Anderson experience and review of the literature J Urol 1998 159 714 717
27. K han MA T ravis LB L ynch CF et al p53 mutations in cyclophosphamide- associated bladder cancer Cancer Epidemiol Biomarkers Prev 1998 7 397 403
28. T ihan T F ilippa DA Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence Cancer 1996 77 2325 2331
29. T ravis LB C urtis RE G limelius B H olowaty EJ van L eeuwen FE L ynch CF H agenbeek A S tovall M B anks PM A dami J et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma J Natl Cancer Inst 1995 87 524 530
30. van L eeuwen FE K lokman WJ S tovall M H agenbeek A van den B elt -D usebout AW N oyon R B oice JD Jr. B urgers JM S omers R Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease J Natl Cancer Inst 1995 87 1530 1537
31. K aldor JM D ay NE B ell J et al. Lung cancer following Hodgkin's disease: a case-control study Int J Cancer 1992 52 677 681
32. B aron JA R ohan TE Tobacco In S chottlenfeld D F raumeni JF eds Cancer Epidemiology and Prevention 2nd edn New York Oxford University Press 1996 269 289
33. D ores GM M etayer C C urtis RE et al Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years J Clin Oncol 2002 20 3484 3494
34. S tagnaro E T umino R P arodi S et al Non Hodgkin's lymphomas and type of tobacco smoke Cancer Epidemiol Biomarkers Prev 2004 13 431 437
35. P each HG B arnett NE Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma Hematol Oncol 2001 19 67 80
36. O'B rien TR K irk G Z hang M Hepatocellular carcinoma: paradigm of preventive oncology Cancer J 2004 10 67 73